• Rationale and Comments

    Colposcopy for low-grade abnormalities in this group does not detect recurrence unless there is a visible lesion and is not cost effective.

    Sponsoring Organizations

    • Society of Gynecologic Oncology


    • Expert consensus


    • Gynecologic
    • Oncologic


    • Rimel BJ, Ferda A, Erwin J, Dewdney SB, Seamon L, Gao F, DeSimone C, Cotney KK, Huh W, Massad LS. Cervicovaginal cytology in the detection of recurrence after cervical cancer treatment. Obstet Gynecol. 2011;118:548-53.
    • Tergas A HL, Guntupalli SR, Huh WK, Massad LS, Fader AN, Rimel BJ. A cost analysis of colposcopy following abnormal cytology in posttreatment surveillance for cervical cancer. Gynecol Oncol. 2013.